ARCHIFAR

This brand name is authorized in Cyprus, Spain, Croatia, Malta, Romania, Singapore, Tunisia

Active ingredients

The drug ARCHIFAR contains one active pharmaceutical ingredient (API):

1 Meropenem UNII FV9J3JU8B1 - MEROPENEM

Meropenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs). Read about Meropenem

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ARCHIFAR Powder for solution for injection / infusion	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DH02	Meropenem	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 83988, 83989
Country: MT	Medicines Authority	Identifier(s): MA032/07903, MA032/07904
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61142001, W61142002, W61142003, W61142004, W61142005, W61143001, W61143002, W61143003, W61143004, W61143005
Country: SG	Health Sciences Authority	Identifier(s): 14445P, 14844P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6973231H